Back

Increased granulocyte neprilysin (CD10) expression is associated with better prognosis in patients with heart failure with reduced ejection fraction

25 May 2019 (09:00 - 09:06)
Organised by:
Congress Presentation Part of: Rapid Fire 1 - Basic Science Heart Failure with Reduced Ejection Fraction (HFrEF) HFA Premium Access Heart Failure 2019

About the speaker

Photo
Doctor Henrike Arfsten

Medical University of Vienna, Vienna (Austria)

11 More presentations in this session

Presentation thumbnail
Dual Regulation of SUMO2 and STAT1 by HectD3 Protects Heart from Hypertrophy and Inflammation
Doctor A. Rangrez (Kiel, DE)
Abstract
Presentation thumbnail
A translational mouse model of HFpEF
Mr A. Withaar (Groningen, NL)
Abstract Slides Video
Presentation thumbnail
Diastolic dysfunction and HFpEF characteristics are exacerbated with ageing in smoothelin-like 1 (SMTNL1)-deficient mice
Ms M. Murali (Calgary, CA)
Abstract Slides Video
Presentation thumbnail
L-2-hydroxyglutarate dehydrogenase (L2HGDH) is a novel metabolic target protecting from cardiac hypertrophy and heart failure
Doctor A. Remes (Kiel, DE)
Abstract Slides Video
Presentation thumbnail
Purified exosome product and extracellular vesicles: treatment for acute myocarditis, dilated cardiomyopathy and heart failure
Doctor K. Bruno (Jacksonville, US)
Abstract Slides Video

Access the full session

Session thumbnail
Rapid Fire 1 - Basic Science

The Event

Event poster

Heart Failure 2019

25 May 2019 09:00 CET
You may be interested in
thumbnail
Congress Presentation
The prognostic significance of the neutrophil-to-lymphocyte ratio in patients with acute decompensated heart failure
29 June 2021
thumbnail
Congress Session
Biomarkers in the era of 'OMICS': potential beyond diagnosis
19 May 2025
thumbnail
Congress Presentation
Impact of prolonged use of angiotensin receptor-neprilysin inhibitors versus angiotensin-converting enzyme inhibitors/angiotensin receptor blockers in patients with heart failure reduced ejection frac
21 May 2023
thumbnail
Congress Presentation
The association between circulating B cell count and clinical outcomes in patients with heart failure
30 August 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources